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ABSTRACT
CpG islands (CGIs) are associated with the majority
of mammalian gene promoters and function to re-
cruit chromatin modifying enzymes. It has therefore
been proposed that CGIs regulate gene expression
through chromatin-based mechanisms, however in
most cases this has not been directly tested. Here, we
reveal that the histone H3 lysine 36 (H3K36) demethy-
lase activity of the CGI-binding KDM2 proteins con-
tributes only modestly to the H3K36me2-depleted
state at CGI-associated gene promoters and is dis-
pensable for normal gene expression. Instead, we
discover that KDM2 proteins play a widespread and
demethylase-independent role in constraining gene
expression from CGI-associated gene promoters. We
further show that KDM2 proteins shape RNA Poly-
merase II occupancy but not chromatin accessibility
at CGI-associated promoters. Together this reveals a
demethylase-independent role for KDM2 proteins in
transcriptional repression and uncovers a new func-
tion for CGIs in constraining gene expression.
INTRODUCTION
The functionality of complex multicellular organisms is un-
derpinned by the creation of diverse cell types from a com-
mon genetic DNA blueprint. This is achieved during devel-
opment by cells acquiring andmaintaining cell type-specific
gene expression programmes. At the most basic level, this
relies on the control of RNA polymerase II (RNAPII)-
mediated transcription by transcription factors (1). How-
ever, it has also become clear that chromatin structure and
its chemical modification can profoundly affect how tran-
scription initiates from promoters and how gene expression
is controlled (2,3).
One such chemical modification of chromatin occurs on
DNA where a methyl group is added to the five position
of each cytosine in the context of CpG dinucleotides. CpG
methylation is pervasive in mammalian genomes and is gen-
erally associated with transcriptional repression, particu-
larly of repetitive and parasitic DNA elements (4,5). How-
ever, short CpG-rich regions of the genome, called CpG
islands (CGIs), remain free of DNA methylation and are
associated with the majority of mammalian gene promot-
ers (6,7). CGIs have been proposed to regulate gene ex-
pression (8,9) through a family of ZF-CxxC DNA binding
domain-containing proteins that recognize non-methylated
DNA and occupy CGIs (10–13). Interestingly, most ZF-
CxxC domain-containing proteins possess histone modi-
fying activities or are part of large chromatin modifying
complexes, suggesting that these factors regulate gene ex-
pression through chromatin (14). However, in most cases
the contribution of chromatin-based mechanisms to CGI-
dependent gene regulation remains untested.
The ZF-CxxC domain-containing protein lysine-specific
demethylase 2A (KDM2A) and its paralogueKDM2Bbind
toCGIs (12,15–17).KDM2proteins encode a JmjCdomain
that catalyses the removal of H3K36 mono- and di- methy-
lation (H3K36me1/2) (18–22). H3K36me1/2 are broadly
distributed throughout the mammalian genome (23–25)
and H3K36me2 has been proposed to counteract tran-
scription initiation. For example, in yeast H3K36me2 in-
hibits inappropriate initiation of transcription from cryp-
tic promoters in genes (26–30), and this function may also
be conserved in mammals (31,32). Given the seemingly
widespread and indiscriminate deposition of H3K36me1/2
in mammalian genomes and its association with transcrip-
tional repression, the discovery that KDM2 proteins lo-
calize specifically to CGIs has led to the suggestion that
the removal of H3K36me2 at these sites may contribute
to a widespread and transcriptionally permissive chromatin
state at gene promoters (8,9). Depletion of KDM2A was
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shown to cause an increase in H3K36me2 at a number of
CGI-associated gene promoters, suggesting that KDM2A
plays an active role in H3K36me2 removal (12). However,
the histone demethylase activity of KDM2 proteins has
also been linked to gene repression, including of genes that
have roles in cell proliferation, differentiation and senes-
cence (19,33–37). Therefore, the role that KDM2 proteins
play in regulating H3K36me1/2 and the effect that this has
on CGI-associated gene transcription remain unclear.
KDM2 proteins may also regulate transcription through
mechanisms that do not rely on their demethylase activity.
KDM2A has been implicated in the formation of pericen-
tromeric heterochromatin (38), whilst KDM2B physically
associates with polycomb repressive complex 1 (PRC1) and
is required for the formation of repressive polycomb chro-
matin domains at a subset of CGI-associated gene promot-
ers (15–17,22,39–41). The possibility that KDM2 proteins
have demethylase-independent activity is supported by the
observation that theKdm2a andKdm2b genes encode inter-
nal transcription start sites (TSS) downstream of their JmjC
domain. Transcription initiating from these alternative pro-
moters gives rise to short forms of KDM2A and KDM2B
(KDM2A/B-SF, Figure 1A) that lack the JmjC domain
and therefore cannot act as histone demethylases (14,37).
Importantly, however, they retain their ZF-CxxC domain
and CGI binding activity. The function of KDM2A/B-
SF proteins remains poorly defined, but there is evidence
that the KDM2B-SF is sufficient to recruit PRC1 to chro-
matin (39). Following the depletion of either KDM2A or
KDM2B, alterations in gene expression have been reported
(12,15,17,39,42). However, whether these two closely re-
lated paralogues function cooperatively to regulate gene ex-
pression is unknown and, like many chromatin modifying
enzymes, it remains largely untested whether they rely on
their enzymatic activity for gene regulation. Perhaps more
fundamentally, whether the KDM2 proteins function pri-
marily to potentiate or repress gene transcription has not
been examined at the genome-scale and remains a major
conceptual barrier in understanding how CGIs, which are
associated with most vertebrate gene promoters, control
gene transcription and expression.
To address these fundamental questions, here we have
exploited systematic conditional genetic ablation strate-
gies and detailed genome-wide analysis to dissect how
KDM2 proteins regulate H3K36me2 and gene expres-
sion in mouse embryonic stem cells (mESCs). We dis-
cover that KDM2 proteins contribute only modestly to
the H3K36me2-depleted state at CGI-associated gene pro-
moters and the demethylase activity of KDM2 proteins is
largely dispensable for normal gene expression. In contrast,
surgical removal of the KDM2 ZF-CxxC domains, which
liberates KDM2 proteins fromCGIs, revealed a widespread
increase in gene expression. This was not limited to the func-
tion ofKDM2B in polycomb-mediated gene repression, but
instead occurred broadly across CGI-associated genes, re-
vealing an unexpectedly widespread role for KDM2 pro-
teins in constraining gene expression. KDM2B plays the
predominant role in gene repression, whilst KDM2A ap-
pears to cooperate with KDM2B to counteract expression
at a subset of genes. KDM2-dependent effects on gene ex-
pression do not manifest through alteredDNA accessibility
at CGIs, but instead appear to regulate RNAPII occupancy
at gene promoters. Therefore, we define a new demethylase-
independent role for KDM2A/B in transcriptional repres-
sion, uncovering a new logic whereby CGIs appear, unex-
pectedly, to constrain gene expression.
MATERIALS AND METHODS
Cell culture
Mouse embryonic stem cells (mESCs) were cultured on
gelatine-coated dishes at 37◦C and 5% CO2, in Dulbecco’s
modified Eagle’s medium (DMEM) (Life Technologies)
supplemented with 15% fetal bovine serum (Labtech),
2mM L-glutamine (Life Technologies), 0.5 mM beta-
mercaptoethanol (Life Technologies), 1× non-essential
amino acids (Life Technologies), 1x penicillin-streptomycin
(Life Technologies) and 10 ng/ml leukemia-inhibitory fac-
tor. Conditional mESC lines were treated with 800 nM
4-hydroxytamoxifen (Sigma) for 96 h to induce KDM2-
LFs knockout (Kdm2a/b-JmjCfl/fl) or ZF-CxxC domain
deletion (Kdm2a/b-CXXCfl/fl, Kdm2a-CXXCfl/fl, Kdm2b-
CXXCfl/fl). For embryoid body differentiation, 106 mESCs
were plated on non-adhesive 10 cm dishes in EC-10medium
and cultured for the indicated number of days.
Human HEK293T cells used for KDM2A/B and
RNAPII cChIP-seq were grown at 37◦C and 5% CO2 in
DMEM supplemented with 10% fetal bovine serum, 2
mM L-glutamine, 0.5 mM beta-mercaptoethanol and 1×
penicillin-streptomycin. Drosophila melanogaster S2 (SG4)
cells used for cnRNA-seq were grown adhesively at 25◦C in
Schneider’s Drosophila Medium (Life Technologies), sup-
plemented with 1× penicillin-streptomycin and 10% heat-
inactivated fetal bovine serum.
Generation of the Kdm2a/b-JmjCfl/fl mESC line
To generate the Kdm2a/b-JmjCfl/fl mESC line, a loxP
site was inserted upstream of the critical JmjC domain-
encoding exon(s) in the Kdm2a and Kdm2b genes (exon 8
for Kdm2a, and exons 7–8 for Kdm2b), and FRT flanked
PGK-neo and a second loxP site were inserted downstream
of the critical exon(s). Targeting vectors were generated
from bacterial artificial chromosomes containing the target
mouse genomic regions using the Double Red recombina-
tion method, as previously described (43). Linearized tar-
geting vectors were introduced into M1 mESCs by electro-
poration (GenePulser, Bio-Rad). mESC colonies were iso-
lated and expanded, and the genomic DNA of each clone
was purified. Homozygous loxP targeting was verified by
sequencing of the genomic region surrounding the loxP
sites. Targeted mESCs were injected into mouse blastocysts
to generate chimeric mice. The Kdm2a/b-JmjCfl/fl line was
generated by removal of the PGK-neo marker gene by mat-
ing the targeted mice with mice expressing FLP recom-
binase. These Kdm2a/b-JmjCfl/fl mice were further mated
withmice harboring theROSA26-CreErt2 locus to generate
Kdm2a/b-JmjCfl/fl:ROSA26-CreErt2+/− mice, from which
the Kdm2a/b-JmjCfl/fl mESCs used in this study were de-
rived.
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Generation of Kdm2a-CXXCfl/fl and Kdm2a/b-CXXCfl/fl
mESC lines
Conditional Kdm2a-CXXCfl/fl and Kdm2a/b-CXXCfl/fl
mESC lines were generated by using CRISPR-mediated
genome editing to insert parallel loxP sites flanking
exon 14 of the Kdm2a gene in Rosa26::CreERT2 or
Kdm2b-CXXCfl/fl mESCs, respectively (39). Targeting
constructs encoding the loxP sequence flanked by 150 bp
homology arms and carrying a mutated PAM sequence to
prevent retargeting by the Cas9 enzyme were purchased
from GeneArt (ThermoFisher). The pSpCas9(BB)-2A-
Puro(PX459)-V2.0 vector was obtained from Addgene
(#62988). sgRNAs were designed using the CRISPOR
online tool (http://crispor.tefor.net/crispor.py) and were
cloned into the vector as previously described (44). First,
the upstream loxP site was targeted. Rosa26::CreERT2 or
Kdm2b-CXXCfl/fl mESCs were transiently co-transfected
with 1 g of Cas9-sgRNA plasmid and 3.5 g of targeting
construct using Lipofectamine 3000 (ThermoFisher). The
day after transfection, cells were passaged at a range of
densities and subjected to puromycin selection (1 g/ml)
for 48 h. Individual clones were isolated and screened by
polymerase chain reaction (PCR). A correctly targeted
homozygous clone was then used to target the down-
stream loxP site using the same transfection protocol and
screening strategy. Correct loxP targeting was verified by
sequencing of the genomic region surround the loxP sites,
and clones were analysed by both RT-qPCR and western
blot to confirm loss of the ZF-CxxC domain in response to
tamoxifen treatment.
Protein extracts and immunoblotting
For nuclear extraction, mESCs were washed with
phosphate-buffered saline (PBS) then resuspended in
10 volumes of Buffer A (10 mM Hepes pH 7.9, 1.5 mM
MgCl2, 10 mM KCl, 0.5 mM DL-dithiothreitol (DTT),
0.5 mM phenylmethylsulfonyl fluoride (PMSF) and 1×
PIC (Roche)) and incubated on ice for 10 min. Cells
were recovered by centrifugation at 1500 g for 5 min,
resuspended in three volumes of Buffer A supplemented
with 0.1% NP-40 and incubated on ice for 10 min. The
released nuclei were recovered by centrifugation at 1500
g for 5 min and resuspended in 1 pellet volume of Buffer
B (5 mM Hepes pH 7.9, 26% glycerol, 400 mM NaCl,
1.5 mM MgCl2, 0.2 mM ethylenediaminetetraacetic acid
(EDTA), 0.5 mM DTT and 1× PIC). After 1 h of rotation
at 4◦C, the suspension was pelleted at 16 000 g for 20 min
and the supernatant taken as nuclear extract.
For histone extraction, mESCs were washed with RSB
(10 mM Tris–HCl pH 7.4, 10 mM NaCl, 3 mM MgCl2
and 20mMNEM), then resuspended in RSB buffer supple-
mented with 0.5%NP-40 and incubated on ice for 10 min to
allow cell lysis. Following centrifugation at 500 g for 5 min,
the nuclear pellet was incubated in 2.5 mM MgCl2, 0.4M
HCl and 20 mM NEM on ice for 20 min. After centrifuga-
tion at 16 000 g for 20 min, histones were precipitated from
the supernatant on ice with 25% TCA for 30 min. Histones
were recovered by centrifugation at 16 000 g for 15 min,
and the pellet was washed twice in acetone. The histone pel-
let was resuspended in 1× sodium dodecyl sulphate (SDS)
loading buffer and boiled at 95◦C for 5 min. Any insolu-
ble precipitate was pelleted by centrifugation at 16 000 g for
15 min and the soluble fraction retained as histone extract.
Histone concentrations were compared by Coomassie Blue
staining following SDS-polyacrylamide gel electrophoresis.
Semi-quantitative western blot analysis of histone extracts
was performed using LiCOR IRDye® secondary antibod-
ies and the LiCOROdyssey Fc system. Tomeasure changes
in H3K36methylation, the signal relative to histone H4 was
determined.
Antibodies
The following antibodies were used in this study: anti-
KDM2A (12), anti-KDM2B (15), anti-BRG1 (EPN-
CIR111A, Abcam), anti-H3, anti-H3K36me1, anti-
H3K36me2 (12), anti-H3K36me3, anti-H4 (L64C1, Cell
Signalling), anti-H2AK119ub1 (D27C4, Cell Signalling),
anti-H3K27me3 (45), anti-Rbp1-NTD (D8L4Y, Cell Sig-
nalling), anti-Rbp1-CTD-Ser5P (D9N5I, Cell Signalling),
anti-Rbp1-CTD-Ser2P (E1Z3G, Cell Signalling). Anti-H3
and anti-H3K36me antibodies were prepared in-house
by rabbit immunization with synthetic peptides (PTU/BS
Scottish National Blood Transfusion Service) and antibod-
ies were purified on peptide affinity columns.
Preparation of chromatin
For histone H3 and H3K36me2 ChIP, 1× 107 mESCs were
crosslinked for 10 min in 1% formaldehyde. Reactions were
quenched by addition of 125 mM glycine. The released nu-
clei were washed twice in PBS, then resuspended in lysis
buffer (1% SDS, 10 mM EDTA, 50 mM Tris–HCl pH 8.1
and 1 × PIC) and incubated on ice for 30 min.
For KDM2A/B ChIP, 5 × 107 mESCs were resuspended
in PBS and mixed with 2 × 106 HEK293T cells. Cells were
crosslinked in 2 mM disuccinimidyl glutarate (Thermo Sci-
entific) for 45 min at 25◦C with gentle rotation, then in
1% formaldehyde for 12.5 min (methanol-free, Life Tech-
nologies). Reactions were quenched by addition of 125
mM glycine, and crosslinked cells were resuspended in ly-
sis buffer (50 mM HEPES-KOH pH 7.9, 140 mM NaCl,
1 mM EDTA, 10% glycerol, 0.5% NP40, 0.25% TritonX-
100 and 1× PIC) and rotated for 10 min at 4◦C. The re-
leased nuclei were washed (10 mM Tris–HCl pH 8.0, 200
mM NaCl, 1 mM EDTA, 0.5 mM EGTA and 1× PIC) for
5 min at 4◦C, and the nuclear pellet resuspended in 1 ml
sonication buffer (10 mMTris–HCl pH 8.0, 100 mMNaCl,
1 mM EDTA, 0.5 mM EGTA, 0.1% sodium deoxycholate,
0.5% N-lauroylsarcosine and 1× PIC).
For RNAPII ChIP, 5 × 107 mESCs were resuspended
in PBS and mixed with 4 × 106 HEK293T cells. Cells
were crosslinked for 10 min in 1% formaldehyde. Reac-
tions were quenched by addition of 150 mM glycine and the
crosslinked cells resuspended in FA-lysis buffer for 10 min
(50 mM HEPES pH 7.9, 150 mM NaCl, 2 mM EDTA, 0.5
mM EGTA, 0.5% NP40, 0.1% sodium deoxycholate, 0.1%
SDS, 10 mM NaF, 1 mM AEBSF, 1×PIC).
Chromatin was sonicated using a BioRuptor Pico son-
icator (Diagenode), shearing genomic DNA to ∼0.5 kb.
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Sonicated chromatin was diluted 10-fold in ChIP dilution
buffer (1% TritonX-100, 1 mM EDTA, 20 mM Tris–HCl
pH 8, 150 mM NaCl and 1× PIC) for H3, H3K36me2 or
KDM2A/B ChIP, or in FA-lysis buffer for RNAPII ChIP.
For H2AK119ub1 and H3K27me3 ChIP, native chro-
matin was prepared as previously described (46).
Chromatin immunoprecipitation and sequencing
For fixed ChIP, chromatin was pre-cleared for 1 h with ei-
ther protein A agarose beads (Repligen, for H3, H3K36me2
or RNAPII ChIP) or protein A magnetic Dynabeads (In-
vitrogen, for KDM2A/B ChIP) blocked with 1 mg/ml
bovine serum albumin (BSA) and 1 mg/ml yeast tRNA.
For each ChIP reaction, 150 g chromatin (KDM2A/B),
300 g chromatin (RNAPII) or chromatin correspond-
ing to 1 × 105 cells (H3 or H3K36me2 ChIP) was incu-
bated overnight with the appropriate antibody: anti-H3 (15
l), anti-H3K36me2 (15 l), anti-KDM2A (1.2 l), anti-
KDM2B (1 l), anti-Rbp1-NTD (15 l), anti-Rbp1-CTD-
Ser5P (12.5 l), anti-Rbp1-CTD-Ser2P (12.5 l).
Antibody-bound chromatin was isolated using blocked
protein A agarose (H3, H3K63me2 or RNAPII ChIP) or
magnetic beads (KDM2A/B ChIP) for 2 h at 4◦C. For H3,
H3K36me2 or KDM2A/B ChIP, washes were performed
with low salt buffer (0.1% SDS, 1% TritonX-100, 2 mM
EDTA, 20 mM Tris–HCl pH 8, 150 mM NaCl), high salt
buffer (0.1% SDS, 1% TritonX-100, 2 mM EDTA, 20 mM
Tris–HCl pH 8, 500 mMNaCl), LiCl buffer (250 mMLiCl,
1% NP40, 1% sodium deoxycholate, 1 mM EDTA, 10 mM
Tris–HCl pH 8) and two washes with TE buffer (10 mM
Tris–HCl pH 8, 1 mM EDTA). For RNAPII ChIP, washes
were performed with FA-Lysis buffer, FA-Lysis buffer con-
taining 500 mM NaCl, DOC buffer (250 mM LiCl, 0.5%
NP40, 0.5% sodium deoxycholate, 2 mM EDTA, 10 mM
Tris–HCl pH 8) and twowashes with TE buffer. ChIPDNA
was eluted in elution buffer (1% SDS, 100 mM NaHCO3)
and crosslinks reversed overnight at 65◦C with 200 mM
NaCl and 2 l RNase A (Sigma). A matched input sam-
ple (corresponding to 10% of original ChIP reaction) was
treated identically. The following day, samples were treated
with 20 g/ml Proteinase K (Sigma) for 2 h at 45◦C and
purified using the ChIP DNA Clean and Concentrator Kit
(Zymo Research).
For H2AK119ub1 or H3K27me3 ChIP, S1/S2 nucleo-
somes were diluted 10-fold in native ChIP incubation buffer
(70 mM NaCl, 10 mM Tris–HCl pH 7.5, 2 mM MgCl2, 2
mMEDTA, 0.1%TritonX-100, 10mMNEM, 1×PIC). For
each ChIP reaction, 1 ml of diluted nucleosomes was incu-
bated overnight at 4◦C with 5 l of anti-H2AK119ub1 or
anti-H3K27me3 antibody. Antibody-bound nucleosomes
were isolated by incubation for 1 h at 4◦C with protein A
agarose beads, which were pre-blocked overnight in native
ChIP incubation buffer supplemented with 1 mg/ml BSA
and 1 mg/ml yeast tRNA. The beads were then washed
four times with native wash buffer (20 mM Tris–HCl pH
7.5, 2 mM EDTA, 125 mM NaCl, 0.1% TritonX-100) and
once with TE buffer. ChIP DNAwas eluted using 100 l of
elution buffer (1% SDS, 0.1 M NaHCO3), then purified us-
ing the ChIP DNAClean and Concentrator Kit (Zymo Re-
search). DNA from amatched input sample (corresponding
to 10% of original ChIP reaction) was also purified.
ChIP-seq libraries for both ChIP and input samples were
prepared using the NEBNext Ultra DNA Library Prep Kit
for Illumina (NEB), following themanufacturer’s guidelines
and using NEBNextMultiplex Oligos. The average size and
concentration of libraries were determined using the 2100
Bioanalyzer High Sensitivity DNAKit (Agilent) and qPCR
with SensiMix SYBR (Bioline) and KAPA Illumina DNA
standards (Roche). Libraries were sequenced using the Illu-
mina NextSeq 500 platform in biological triplicate or qua-
druplicate with 40 bp paired-end reads.
Calibrated nuclear RNA-sequencing and ATAC-sequencing
(cnRNA-seq and cATAC-seq)
To isolate nuclei for cnRNA-seq and cATAC-seq, 1 × 107
mESCs were mixed with 2.5 × 106 Drosophila SG4 cells in
PBS. Cells were lysed in 1 ml HS lysis buffer (0.05% NP40,
50 mM KCl, 10 mM MgSO4.7H20, 5 mM HEPES, 1 mM
PMSF, 3 mMDTT, 1× PIC). Nuclei were recovered by cen-
trifugation at 1000 g for 5 min and washed three times in
1 ml resuspension buffer (10 mM NaCl, 10 mM Tris–HCl
pH 7.4, 3 mMMgCl2). Nuclear integrity was assessed using
0.4% trypan blue staining (ThermoFisher).
Nuclear RNA was prepared from 4 × 106 nuclei using
TRIzol reagent according to the manufacturer’s protocol
(Invitrogen), then treated with the TURBO DNA-free kit
(ThermoFisher). nRNAquality was assessed using the 2100
Bioanalyzer RNA 6000 Pico kit (Agilent), then nRNA was
depleted of rRNA using the NEBNext rRNA depletion kit
and the depletion efficiency evaluated using the Bioanlayzer
RNA 6000 Pico kit. RNA-seq libraries were prepared us-
ing the NEBNext Ultra Directional RNA-seq kit, and li-
brary size and concentration was determined as described
for ChIP libraries. Libraries were sequenced using the Illu-
mina NextSeq 500 platform in biological triplicate or qua-
druplicate using 80 bp paired-end reads.
Chromatin accessibility was assayed using an adaptation
of the assay for transposase accessible-chromatin (ATAC)-
seq (47) as previously described (48), using 5 × 105 nu-
clei from the same preparation used for the purification
of nuclear RNA. Genomic DNA was also purified from
an aliquot of the same preparation of nuclei by phenol-
chloroform extraction and tagmented with Tn5, to control
for sequence bias of the Tn5 transposase and to determine
the exact mouse/flymixing ratio for each individual sample.
ATAC-seq and input gDNA libraries were prepared by
PCR amplification using custom-made Illumina barcodes
(47) and the NEBNext High-Fidelity 2X PCRMaster Mix.
Libraries were purified with two rounds of Agencourt AM-
Pure XP bead cleanup (Agencourt, 1.5× bead:sample ra-
tio). Library size and concentration were determined as de-
scribed for ChIP libraries. Libraries were sequenced using
the Illumina NextSeq 500 platform in biological triplicate
or quadruplicate using 80 bp paired-end reads.
Droplet digital PCR
For droplet digital PCR (ddPCR), total RNAwas prepared
from 106 mESCs using the RNeasy mini plus kit including
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gDNA eliminator columns (QIAGEN). RPT low retention
tips (Starlab) were used throughout the ddPCR protocol to
increase pipetting accuracy. Purified RNA was eluted in 30
l elution buffer, 7 l was diluted with 8 l water and 4 l
of this dilution was reverse transcribed using the imProm-
II system with random hexamer primers and RNasin ri-
bonuclease inhibitor (Promega). The generated cDNA was
diluted with 300 l nuclease-free water. ddPCR primers
were designed using Primer 3 Plus (49) with BioRad recom-
mended settings: 3.8 mM divalent cations, 0.8 mM dNTPs,
80–120 bp product, 60–61◦Cmelting temperature. Their ef-
ficiency was tested using a serial dilution curve of cDNA
by standard SYBR qPCR. ddPCR reactions were prepared
in 96-well PCR plates, and contained 12.5 l 2× QX200
ddPCR EvaGreen Supermix (BioRad), 0.32 l each of for-
ward and reverse primers (10 M), 7 l diluted cDNA and
4.86 l nuclease-free water. This 25 l reaction was mixed
by pipetting, then 22 l was transferred to a semi-skirted
96-well PCRplate (Eppendorf) and used for droplet genera-
tion with an AutoDGdroplet generator (BioRad). Droplets
were collected in a semi-skirted PCR plate, which was then
sealed using a PX1 PCR plate sealer (BioRad). PCR was
performed using a C1000 Touch thermal cycler (BioRad)
with a 2◦C/s ramp rate: 5 min at 95◦C followed by 40 cycles
of denaturation at 95◦C for 30 s and annealing/extension
at 60◦C for 60 s, then signal stabilization at 4◦C for 5 min
followed by 90◦C for 5 min. Droplets were sorted into PCR-
positive and PCR-negative fractions according to their flu-
orescence using the QX200 droplet reader (BioRad). Quan-
taLife software (BioRad) was used to calculate the absolute
concentration of template cDNA in the ddPCR reaction.
Data processing and normalization of massively parallel se-
quencing
For cATAC-seq and KDM2A, KDM2B and RNAPII
cChIP-seq (including sequencing of input gDNA), reads
were aligned to concatenated mouse and spike-in genomes
(mm10+dm6 or mm10+hg19) using Bowtie 2 with the
‘– no-mixed’ and ‘– no-discordant’ options (50). For hi-
stone ChIP-seq, reads were aligned to the mouse mm10
genome as above. Reads that were mapped more than once
were discarded, and PCR duplicates were removed using
SAMTools (51). For cATAC-seq, reads that mapped to a
custom ‘blacklist’ of genomic regions with artificially high
counts, including mitochondrial DNA sequences, were also
discarded.
For cnRNA-seq, reads were first aligned using Bowtie
2 (with ‘–very-fast’, ‘–no-mixed’ and ‘–no-discordant’ op-
tions) to the concatenated mm10 and dm6 rRNA genomic
sequence (GenBank: BK000964.3 and M21017.1) to filter
out reads mapping to rRNA. All unmapped reads were
aligned to the concatenated mm10+dm6 genome using
STAR (52). To improve mapping of intronic sequences,
reads that failed to map using STAR were aligned us-
ing Bowtie 2, with ‘–sensitive-local’, ‘–no-mixed’ and ‘–no-
discordant’ options. PCR duplicates were removed using
SAMtools (51).
To internally calibrate cnRNA-seq, cATAC-seq and
cChIP-seq experiments we spiked a fixed number of control
cells into each sample (Drosophila SG4 cells for cnRNA-seq
and cATAC-seq, human HEK293T cells for KDM2A/B
and RNAPII cChIP-seq). This spike-in genome was then
used to quantitatively compare the gene expression, chro-
matin accessibility or ChIP-seq profiles between experimen-
tal conditions. For visualization of cATAC-seq and cChIP-
seq data, mm10 reads were randomly subsampled by a fac-
tor that reflects the total number of spike-in reads in the
same sample, as previously described (53–55). To account
for any variation in the exact spike-in cell: mESC mixing
ratio between biological replicates, the subsampling factors
were additionally corrected according to the ratio of dm6
(or hg19)/mm10 total read counts in the matched input
sample. For visualization of cnRNA-seq data, mm10 reads
were randomly subsampled by Drosophila normalized size
factors calculated usingDESeq2 (see below).HistoneChIP-
seq libraries were randomly downsampled to achieve the
same total number of reads for each individual replicate us-
ing SAMtools (51).
Read count quantitation and analysis
To compare replicates, read coverage across regions of in-
terest (gene bodies for cnRNA-seq and ChIP-seq, gene
promoters for cATAC-seq) was analysed using deepTools
multiBamSummary and plotCorrelation functions (56).
For each condition, biological replicates correlated well
with each other (Pearson correlation coefficient> 0.95) and
were merged for downstream applications.
Genome coverage tracks were generated using the pileup
function from MACS2 (57) for ChIP-seq and ATAC-seq
and genomeCoverageBed from BEDtools (58) for cnRNA-
seq and visualized using the UCSC genome browser (59).
Differential bigwig tracks of H3K36me2 normalized to H3
or ofRNAPII signal in tamoxifen-treated versus –untreated
cells were generated from merged bigwig files using the
deepTools bigwigCompare function with ‘–operation ratio’
setting (56).Metaplot and heatmap analyses of read density
were performed using the computeMatrix, plotProfile and
plotHeatmap deepTools functions (v3.0.1). For ChIP-seq,
intervals of interest were annotated with normalized read
counts from merged replicates with a custom Perl script us-
ing SAMtools, or from differential bigwig files using deep-
Tools computeMatrix with the ‘–outFileNameMatrix’ op-
tion. Correlation analyses were performed inRusing Spear-
man correlation and visualized with scatterplots coloured
by density using ‘stat density2d’.
Differential ATAC-seq and gene expression analyses
DESeq2 (60) was used with a custom R script to iden-
tify significant changes in chromatin accessibility or gene
expression. In order to calibrate to the spike-in genome,
Drosophila reads were first pre-normalized according to the
exact dm6/mm10 spike-in ratio derived from the matched
input gDNA sample.Drosophila read counts were then gen-
erated for a set of unique dm6 refGene genes and used to
calculate DESeq2 size factors. These size factors were sup-
plied for DESeq2 normalization of raw mm10 read counts
for a custom non-redundant mm10 gene set of 20633 genes.
P-adj < 0.05 and fold change > 1.4 thresholds were used to
determine significant changes. Log2 fold changes were visu-
alized using MA-plots generated with ggplot2.
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Gene annotation
Non-redundant mouse genes (n = 20633) were classified
into non-CGI, PRC and non-PRC categories based on
the presence of a non-methylated CGI and RING1B and
SUZ12 binding at their promoters. Gene Ontology analy-
sis was performed using DAVID (61). The BP FAT setting
and an FDR< 0.1 cut-off were used, and the complete non-
redundant mm10 gene set was used as a background.
Accession numbers
The following previously published datasets were used for
analysis: H3K36me3 ChIP-seq (GSE34520) (62), BioCAP
(GSE43512) (63), Pcgf1fl/fl cnRNA-seq, RING1B ChIP-
seq and SUZ12 ChIP-seq (GSE119620) (46).
RESULTS
KDM2 proteins contribute modestly to the H3K36me2-
depleted state at CGI-associated gene promoters
KDM2A and KDM2B both catalyse H3K36me2 demethy-
lation via their JmjC domain (19,20) and localize to CGIs
via their ZF-CxxC domain (Figure 1A) (12,15–17). How-
ever, whether KDM2 proteins regulate H3K36me2 at CGI-
associated gene promoters throughout the genome has not
been examined. Therefore, we generated a mESC system
in which loxP sites were inserted into the Kdm2a and
Kdm2b genes flanking exons that encode the JmjC do-
main (Kdm2a/b-JmjCfl/fl, Supplementary Figure S1A) and
which also expresses a tamoxifen-inducible form of CRE re-
combinase. Addition of tamoxifen triggers deletion of the
JmjC domain-containing exons, removing the long forms
of KDM2A and KDM2B (KDM2-LFs) and their associ-
ated demethylase activity (Figure 1B and C; Supplemen-
tary Figure S1B). Importantly, KDM2-SFs, which are ex-
pressed from downstream promoters (Supplementary Fig-
ure S1A), were unaffected by removal of the KDM2-LFs
(Figure 1 B and C). We first investigated the contribution of
KDM2-LFs to global H3K36methylation levels by western
blot, and observed onlyminor changes following removal of
KDM2-LFs (Supplementary Figure S1C and D). Next, we
examined the genome-wide distribution of H3K36me2 us-
ing chromatin immunoprecipitation followed by massively
parallel sequencing (ChIP-seq). This confirmed a local de-
pletion of H3K36me2 at CGI-associated gene promoters
(Figure 1D and E; Supplementary Figure S1E) (8,9,12).
H3K36me2 depletion was not detected at non-CGI gene
promoters, demonstrating that this is a CGI-associated
chromatin feature. Following removal of the KDM2-LFs
by tamoxifen treatment, there was a modest increase in
H3K36me2 at the TSS of CGI-associated gene promot-
ers (Figure 1D and E; Supplementary Figure S1E) which
we also validated by ChIP-qPCR (Supplementary Figure
S1F). This demonstrates that KDM2A/B contribute to
the H3K36me2-depleted state at CGIs, in agreement with
single-gene studies examining the KDM2A- or KDM2B-
depleted state (12). Interestingly, intragenic CGIs were also
depleted of H3K36me2 (Figure 1F), although this deple-
tion was on average less pronounced than at CGI promot-
ers, likely due to their lower average CpG density and size
(Supplementary Figure S1G). Importantly, removal of the
KDM2-LFs resulted in an increase in H3K36me2 at intra-
genic CGIs, indicating that their H3K36me2-depleted state
is also shaped by KDM2A/B.
Our ChIP-seq analysis revealed that KDM2-LFs con-
tribute to the H3K36me2-depleted state at CGI-associated
promoters. However, we were curious whether the ef-
fects on H3K36me2 were uniformly distributed or depen-
dent on other features of gene promoters, such as tran-
scriptional activity. Therefore, we separated genes based
on expression level (Supplementary Figure S1H) and ex-
amined H3K36me2 at genes and surrounding regions.
This revealed that CGI-associated TSSs were depleted of
H3K36me2 irrespective of expression level (Figure 1G).
Chromatin surrounding CGI-associated TSSs was blan-
keted by H3K36me2, consistent with this modification
being pervasive in mammalian genomes. The increase in
H3K36me2 at the TSS following KDM2-LF removal was
similar across all expression levels (Figure 1H), consis-
tent with the transcription-independent targeting ofKDM2
proteins to CGI promoters via their ZF-CxxC domains.
Interestingly, highly transcribed genes were also depleted
of H3K36me2 in their gene body (Figure 1G). This did
not result from an enrichment of short genes in the set
of highly transcribed genes (Supplementary Figure S1I),
and was independent of KDM2 demethylase activity. In-
stead this depletion correlated with co-transcriptional con-
version of H3K36me2 to H3K36me3 (Figure 1I and Sup-
plementary Figure S1J) (64–69). Together, these observa-
tions reveal that KDM2 proteins remove H3K36me2 from
CGIs, but unexpectedly their contribution to the depletion
of H3K36me2 at these sites is modest. This suggests that
CGIs could be inherently refractory to H3K36me2 or that
additional H3K36 demethylases may also function at these
regions (see Discussion).
KDM2 demethylase activity contributes minimally to gene
regulation
Depletion ofH3K36me2 at CGI-associated gene promoters
has been proposed to contribute to the generation of a tran-
scriptionally permissive chromatin state (8,9,12). Although
KDM2 proteins appear to contribute only modestly to the
H3K36me2-depleted state at CGIs (Figure 1), we were cu-
rious whether this effect was nevertheless required to sus-
tain normal chromatin accessibility and transcription from
CGI-associated gene promoters. To address these ques-
tions, we first performed calibrated ATAC-seq (cATAC-
seq) to measure chromatin accessibility before and after re-
moval of KDM2-LFs. This demonstrated that CGI pro-
moters remained accessible, despite the observed increases
in H3K36me2 (Figure 2A and Supplementary Figure S2A).
To examine gene expression, we performed calibrated nu-
clear RNA sequencing (cnRNA-seq). This revealed that the
expression of the vast majority of genes did not change fol-
lowing removal of KDM2 demethylase activity, with only
a small number of genes being modestly perturbed (Fig-
ure 2B). Furthermore, there was a poor correlation between
gene expression changes and the effects on H3K36me2 at
gene promoters (Figure 2C and D). This minimal perturba-
tion to chromatin accessibility and gene expression follow-
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Figure 1. KDM2 proteins contribute modestly to the H3K36me2-depleted state at CGI-associated gene promoters. (A) A schematic illustrating protein
domain architecture for KDM2A/B long (LF) and short forms (SF). (B) A schematic of the Kdm2a/b-JmjCfl/fl system in which addition of tamoxifen
(OHT) leads to removal of KDM2 long forms. (C) Western blot analysis for KDM2A and KDM2B in Kdm2a/b-JmjCfl/fl mESCs before (UNT) and
after 96 h of tamoxifen (OHT) treatment. BRG1 is shown as a loading control for both blots. Asterisks indicate non-specific bands. (D) Heatmaps of
H3K36me2 enrichment (ChIP-seq) in Kdm2a/b-JmjCfl/fl mESCs before (UNT) and after addition of tamoxifen (OHT), for CGI-associated (n = 14106)
and non-CGI-associated (n= 6527) gene promoters. H3K36me2 signal was normalized toH3ChIP-seq to control for any alterations in nucleosome density.
(E) A metaplot of normalized H3K36me2 ChIP-seq signal at CGI-associated or non-CGI-associated gene promoters in Kdm2a/b-JmjCfl/fl mESCs, before
(UNT) and after tamoxifen treatment (OHT). (F) A metaplot of normalized H3K36me2 ChIP-seq signal at intragenic CGIs in Kdm2a/b-JmjCfl/fl mESCs,
before (UNT) and after tamoxifen treatment (OHT). (G) Metaplots showing normalized H3K36me2 ChIP-seq signal throughout the gene body before
(UNT) and after tamoxifen treatment (OHT), for CGI-associated genes separated into quartiles according to their expression level in Kdm2a/b-JmjCfl/fl
mESCs (Q1<Q2<Q3<Q4). Genes were scaled to the same length and aligned at their TSS and TES. (H) A boxplot showing fold change in normalized
H3K36me2 ChIP-seq signal following tamoxifen treatment, for the CGI-associated gene quartiles shown in (G) and for non-CGI-associated genes. (I) A
metaplot showing H3K36me3 enrichment throughout the gene body for the gene sets shown in (G) (62).
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Figure 2. KDM2demethylase activity contributesminimally to gene regulation. (A) AnMA-plot showing log2 fold change in the accessibility (cATAC-seq)
of CGI-associated gene promoters in Kdm2a/b-JmjCfl/fl mESCs following tamoxifen treatment. No promoters significantly changed in accessibility (p-adj
< 0.05 and > 1.4-fold). (B) An MA-plot showing log2 fold change in gene expression (cnRNA-seq) in Kdm2a/b-JmjCfl/fl mESCs following tamoxifen
treatment. The number of genes with significantly increased or decreased expression (p-adj < 0.05 and > 1.4-fold) is shown in red and density of gene
expression changes is shown on the right. (C) A scatter plot comparing the log2 fold change in gene expression (cnRNA-seq) with the log2 fold change
in normalized H3K36me2 ChIP-seq signal for CGI-associated genes following tamoxifen treatment of Kdm2a/b-JmjCfl/fl mESCs. The solid line shows
the linear regression, and the coefficient of determination (R2) and Spearman correlation coefficient (Cor) are annotated. (D) Boxplots showing the log2
fold change in cnRNA-seq signal (left) and normalized H3K36me2 ChIP-seq signal (right) for CGI-associated genes grouped into quintiles based on their
change in expression following tamoxifen treatment of Kdm2a/b-JmjCfl/fl mESCs.
ing loss of KDM2-LFs indicates that histone demethylase
activity of KDM2 proteins is largely dispensable for normal
CGI-associated promoter activity.
KDM2 proteins play a widespread role in gene repression
Given that gene expression was largely unaffected when
KDM2 demethylase activity was removed, we wondered
whether demethylase-independent activities of KDM2 pro-
teins may play a more prominent role in gene regulation.
KDM2A and KDM2B encode multiple isoforms, each of
which contain the ZF-CxxC DNA binding domain. There-
fore, to remove all CGI-targeted KDM2 proteins, we devel-
oped a conditional mESC system in which the exon encod-
ing the ZF-CxxC domain is flanked by loxP sites in both
Kdm2a and Kdm2b genes (Kdm2a/b-CXXCfl/fl), and which
expresses tamoxifen-inducible CRE recombinase (Supple-
mentary Figure S3A). Following addition of tamoxifen the
ZF-CxxC-encoding exons are excised, producing KDM2A
and KDM2B proteins that now lack the ZF-CxxC domain
(Figure 3A). The effectiveness of this approach was evi-
dent from an increased mobility of the KDM2 proteins in
western blot analysis (Figure 3B). KDM2 proteins lacking
their ZF-CxxC domain no longer bound to CGIs as as-
sessed by ChIP (Figure 3C and D; Supplementary Figure
S3B). Furthermore, we observed an increase in H3K36me2
at CGI-associated gene promoters (Supplementary Figure
S3C) consistent with both long and short formKDM2 pro-
teins dissociating from chromatin.
To examine whether this loss of CGI binding had an
effect on gene expression, we carried out cnRNA-seq
and compared gene expression between untreated and
tamoxifen-treated cells. This revealed that KDM2 protein
removal resulted in more than a fifth of all genes showing
significantly increased expression (Figure 3C and E). Ow-
ing to the quantitative nature of cnRNA-seq it was also ap-
parent that KDM2 protein removal led to a more general
increase in gene expression, even amongst genes that were
not considered significantly changed by statistical analysis
(Figure 3F). We validated these widespread effects using
highly sensitive and quantitative droplet digital PCR anal-
ysis (Supplementary Figure S3D). Importantly, our capac-
ity to uncover this broad increase in gene expression was
only possible due to the use of calibrated nuclear RNA-seq
(cnRNA-seq) as conventional normalization based on to-
tal read count fails to uncover this pervasive alteration in
Nucleic Acids Research, 2019, Vol. 47, No. 17 9013
Figure 3. KDM2 proteins mediate widespread gene repression. (A) A schematic of the Kdm2a/b-CXXCfl/fl system in which addition of tamoxifen (OHT)
leads to the generation of KDM2 proteins that lack the ZF-CxxC domain and therefore are unable to bind to chromatin. (B) Western blot analysis for
KDM2A and KDM2B in Kdm2a/b-CXXCfl/fl mESCs before (UNT) and after 96 h tamoxifen treatment (OHT). BRG1 is shown as a loading control
for both blots. Asterisks indicate non-specific bands. (C) Genomic snapshots showing gene expression (cnRNA-seq) and KDM2A and KDM2B ChIP-
seq before (UNT) and after tamoxifen treatment (OHT) of Kdm2a/b-CXXCfl/flmESCs, for representative genes that moderately (Fbxl20, left) or more
dramatically increased in expression (Fosl2, right). BioCAP signal is shown for reference (63). (D)Metaplots showing enrichment of KDM2A andKDM2B
ChIP-seq signal at the TSS of all CGI-associated genes (n= 14106) before (UNT, blue) and after tamoxifen treatment ofKdm2a/b-CXXCfl/fl mESCs (OHT,
red). (E) AnMA-plot showing log2 fold change in gene expression (cnRNA-seq) inKdm2a/b-CXXCfl/flmESCs following tamoxifen treatment. The number
of genes with significantly increased or decreased expression (p-adj< 0.05 and> 1.4-fold) are shown in red and density of gene expression changes is shown
on the right. (F) A density plot showing the distribution of the log2 fold change in gene expression following tamoxifen treatment of Kdm2a/b-CXXCfl/fl
mESCs, for all genes. (G) A bar graph showing the proportion of genes that have a CGI promoter, for all genes and genes that significantly increased or
decreased in expression following tamoxifen treatment of Kdm2a/b-CXXCfl/fl mESCs.
gene expression (Supplementary Figure S3E). When we ex-
amined in more detail the transcripts with significantly in-
creased expression these were enriched for CGI-associated
genes (Figure 3G), consistent with these effects being a di-
rect result of KDM2 protein removal as opposed to a global
perturbation of some core transcriptional component. In
contrast, significantly downregulated genes were less nu-
merous, not enriched for CGI-associated genes and encom-
passed both polycomb-bound and unbound genes (Supple-
mentary Figure S3F), suggesting they may correspond to
secondary effects. Together, these observations establish an
unexpected and widespread role for KDM2 proteins in sup-
pressing expression from CGI-associated gene promoters.
Elevated gene expression following KDM2 protein removal is
not simply a consequence of polycomb target gene reactiva-
tion
We have previously shown that KDM2B plays an impor-
tant role in recruiting the polycomb repressive complex
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1 (PRC1) to CGI-associated gene promoters in mESCs.
KDM2B does so by binding to an adaptor protein, called
PCGF1, which directly interacts with RING1B, the cat-
alytic core of PRC1 (15–17,39). PRC1 can ubiquitylate hi-
stone H2A at position 119 (H2AK119ub1), which then
stabilizes the second polycomb repressive complex, PRC2,
which can trimethylate histone H3 lysine 27 (H3K27me3).
When we examined the genes that increased in expression
following KDM2 protein removal they had stereotypical
CGI-associated features (Figure 4A), but interestingly were
also enriched for RING1B, a core structural component
of PRC2 (SUZ12), and had H2AK119ub1 and H3K27me3
(Supplementary Figure S4A). In agreement with KDM2B
having the capacity to target the polycomb system to
CGI-associated genes, H2AK119ub1 and H3K27me3 were
reduced at CGI-associated TSSs in tamoxifen-treated
Kdm2a/b-CXXCfl/fl cells (Supplementary Figure S4B–D).
This effect was not evident in Kdm2a/b-JmjCfl/fl cells, in
keeping with our previous observations that the KDM2B
SF is sufficient to target PRC1 (39) (Supplementary Fig-
ure S4E–G). Furthermore, removal of PCGF1, the adap-
tor protein that links KDM2B to PRC1, caused similar
reductions in polycomb-associated histone modifications
(46). The observed effects on polycomb-mediated histone
modifications following tamoxifen treatment of Kdm2a/b-
CXXCfl/fl cells raised the possibility that the widespread
increase in gene expression following KDM2 protein re-
moval may simply result from loss of KDM2B-dependent
targeting and gene repression by the PRC1 complex. To in-
vestigate this possibility, we compared the gene expression
changes following KDM2 protein removal with those fol-
lowing conditional removal of PCGF1 (46). This revealed
that removal of PCGF1 caused de-repression of more than
four times fewer genes than removal of KDM2 proteins
(Figure 4B). Furthermore, genes that significantly increased
in expression following PCGF1 removal weremore strongly
enriched for polycomb target genes than those that signif-
icantly increased following KDM2 removal (Figure 4C).
Genes showing increased expression following PCGF1 re-
moval were a subset of those showing increased expression
following KDM2 protein removal (Figure 4D), and there
was only a moderate positive correlation between the gene
expression changes in these lines (Supplementary Figure
S4H). These observations indicate that a small proportion
of the gene de-repression events in cells where KDM2 pro-
teins are removed are related to the activity of theKDM2B–
PRC1 complex.
Building on this important observation, we examined in
more detail the gene expression changes that manifest from
KDM2 protein removal from CGIs. From this it was ev-
ident that genes with low starting expression level more
strongly increased in expression, including non-polycomb
target genes (Figure 4E). Gene ontology analysis revealed
that genes that significantly increased in expression were
enriched for a variety of developmental terms (Figure 4F),
consistent with some of the effects being related to the poly-
comb system, but also a variety of basic cellular processes
that are unrelated (Figure 4G). This reflects the generalized
increase in gene expression that occurs followingKDM2 re-
moval. Together, these observations reveal that KDM2 pro-
teins play a widespread role in gene repression from CGI-
associated gene promoters and do so largely through mech-
anisms that are independent of the polycomb repressive sys-
tem.
KDM2B plays the predominant role in gene repression
Loss of both KDM2A and KDM2B from CGI chromatin
simultaneously resulted in widespread increases in gene ex-
pression (Figure 3). However, it was unclear from these ex-
periments whether KDM2A, KDM2B or both contribute
to gene repression. To examine this question, we devel-
oped a conditional mESC system in which we could re-
move KDM2A alone by tamoxifen-induced deletion of
its ZF-CxxC domain (Kdm2a-CXXCfl/fl, Figure 5A, Sup-
plementary Figures S5A and S3A). cnRNA-seq revealed
that removal of KDM2A led to virtually no changes in
gene expression (Figure 5B), indicating that KDM2A alone
is not required to maintain normal gene expression in
mESCs. We next investigated the contribution of KDM2B
to the regulation of gene expression, performing cnRNA-
seq using a Kdm2b-CXXCfl/fl mESC line (39) (Figure 5A
and Supplementary Figure S5B). cnRNA-seq revealed that
removal of KDM2B alone was sufficient to cause in-
creases in the expression of thousands of genes (Figure
5B) and, unlike KDM2A removal, largely recapitulated the
widespread increases in gene expression that occurred fol-
lowing KDM2A/B removal (Figure 5C). Genes that signif-
icantly increased in expression following KDM2B removal
were enriched for CGI-associated genes (Figure 5D). Fur-
thermore, gene ontology analysis revealed that these signif-
icantly increasing genes were enriched for a variety of de-
velopmental terms characteristic of polycomb target genes
(Figure 5E) but also terms relating to basic cellular pro-
cesses (Figure 5F). These observations suggest that removal
of KDM2B alone, like removal of KDM2A/B together,
leads to widespread increases in the expression of CGI-
associated genes.
A comparison of the gene expression changes follow-
ing KDM2B removal alone and KDM2A/B removal to-
gether revealed good overall correlation (Figure 5G), indi-
cating that the gene expression changes following KDM2B
removal largely recapitulated those following removal of
KDM2A/B together. However, a more detailed analysis re-
vealed 931 significantly increasing genes that less strongly
increased in expression following loss of KDM2B com-
pared to KDM2A/B together, and this set was enriched for
genes with low expression level (Figure 5H). This suggests
that KDM2A plays a role in restricting the expression of
these genes following KDM2B removal. Together our find-
ings demonstrate that KDM2B plays the predominant role
in repressing gene expression, whilst KDM2A may coop-
erate with KDM2B to counteract expression at a subset of
genes.
KDM2 proteins regulate polymerase occupancy but not chro-
matin accessibility at CGIs
Gene regulatory elements and gene promoters are char-
acterized by elevated chromatin accessibility (70–72), and
this is thought to play an important role in regulating gene
expression. Accessibility at CGI-associated gene promot-
ers broadly correlates with transcriptional output, with the
Nucleic Acids Research, 2019, Vol. 47, No. 17 9015
Figure 4. KDM2-mediated repression is not limited to polycomb target genes. (A) Metaplots showing enrichment of BioCAP signal and KDM2A,
KDM2B, RING1B and SUZ12 ChIP-seq signal at the TSS of all CGI-associated genes (n = 14106, green) and of the subset of these genes that sig-
nificantly increased in expression following tamoxifen treatment of Kdm2a/b-CXXCfl/fl mESCs (n = 3879, red) (46,63). (B) Left: an MA-plot showing
log2 fold change in gene expression (cnRNA-seq) in Pcgf1fl/fl mESCs following tamoxifen treatment to induce PCGF1 knockout (46). The number of
genes with significantly increased or decreased expression (p-adj < 0.05 and > 1.4-fold) is shown in red and density of gene expression changes is shown
on the right. Right: as left but for Kdm2a/b-CXXCfl/fl mESCs, shown for comparison. (C) A bar graph comparing the distribution of genes into three
classes––non-CGI, polycomb (PRC) occupied and non-PRC occupied––for all genes and for genes that significantly increased in expression following
tamoxifen treatment of Pcgf1fl/fl or Kdm2a/b-CXXCfl/fl mESCs. Non-CGI genes are genes that lack a CGI at their promoter. Non-PRC-occupied genes
have a CGI promoter that is not bound by polycomb complexes, whilst PRC-occupied genes have a CGI promoter that is bound by polycomb complexes.
(D) A Venn diagram showing the overlap between genes that significantly increased in expression following tamoxifen treatment of Pcgf1fl/fl andKdm2a/b-
CXXCfl/fl mESCs. (E) A box plot showing the starting expression level (log2 UNT RPKM) for genes grouped into deciles based on their log2 fold change
in expression following tamoxifen treatment of Kdm2a/b-CXXCfl/fl mESCs. (F) Gene ontology analysis of genes that significantly increased in expression
following tamoxifen treatment of Kdm2a/b-CXXCfl/fl mESCs. (G) As (H), but for the subset of significantly increasing genes that were not classified as
polycomb target genes.
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Figure 5. KDM2B plays the predominant role in gene repression. (A) A schematic of theKdm2a-CXXCfl/fl andKdm2b-CXXCfl/fl systems in which addition
of tamoxifen (OHT) leads to the generation of KDM2A or KDM2B proteins that lack the ZF-CxxC domain, respectively, and therefore are unable to
bind to chromatin. (B) MA-plots showing log2 fold change in gene expression (cnRNA-seq) in Kdm2a-CXXCfl/fl (left) or Kdm2b-CXXCfl/fl mESCs (right)
following tamoxifen treatment. The number of genes with significantly increased or decreased expression (p-adj< 0.05 and> 1.4-fold) are shown in red and
density of gene expression changes is shown on the right. (C) A density plot showing the distribution of the log2 fold change in gene expression following
tamoxifen treatment of Kdm2a-CXXCfl/fl, Kdm2b-CXXCfl/fl or Kdm2a/b-CXXCfl/fl mESCs, for all genes. (D) A bar graph illustrating the distribution of
genes between three gene classes (Non-CGI, Non-PRC, PRC) described in Figure 4C, for all genes and for genes that significantly increased or decreased
in expression following tamoxifen treatment of Kdm2b-CXXCfl/fl mESCs. (E) Gene ontology analysis of genes that significantly increased in expression
following tamoxifen treatment of Kdm2b-CXXCfl/fl mESCs. (F) As (E), but for the subset of significantly increasing genes that were not classified as
polycomb target genes. (G) A scatter plot comparing the log2 fold change in gene expression (cnRNA-seq) following tamoxifen treatment of Kdm2b-
CXXCfl/fl and Kdm2a/b-CXXC fl/fl mESCs. The solid line shows the linear regression, and the coefficient of determination (R2) and Spearman correlation
coefficient (Cor) are annotated. (H) A scatter plot of the log2 fold change in gene expression (cnRNA-seq) following tamoxifen treatment of Kdm2a/b-
CXXC fl/fl mESCs for genes that significantly increased in expression, plotted against the ratio of the log2 fold change in gene expression following tamoxifen
treatment ofKdm2b-CXXCfl/fl versusKdm2a/b-CXXCfl/fl mESCs. A 1.5-fold threshold (red dotted lines) was used to define genes which were differentially
regulated between the two datasets, and the number of genes with more than 1.5-fold increased or decreased expression is shown in red. The solid line
shows the linear regression, and the coefficient of determination (R2) and Spearman correlation coefficient (Cor) are annotated.
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promoters of highly transcribed CGI-associated genes be-
ing more highly accessible (73). Therefore we wondered
whether the increases in gene expression following removal
of KDM2 proteins resulted from increases in the accessi-
bility at CGI-associated gene promoters in the absence of
KDM2A/B. To test this we carried out cATAC-seq follow-
ing removal of KDM2 proteins. Importantly, we did not
observe any significant change in the accessibility of CGI-
associated gene promoters (Figure 6A; Supplementary Fig-
ure S6A and B), indicating that expression changes must
manifest through effects on transcription that are indepen-
dent of chromatin accessibility.
To examine this possibility in more detail, we carried
out cChIP-seq for RNAPII before and after removal of
KDM2 proteins. This revealed on average a widespread de-
crease inRNAPII occupancy at the TSSs of CGI-associated
genes (Figure 6B and C), which was reproducible between
replicates (Supplementary Figure S6C). In the gene body,
alterations in RNAPII occupancy appeared to be related
to the level of RNAPII reduction at the gene promoter.
Genes that retained promoter-associated RNAPII showed
increased RNAPII in the gene body and promoters show-
ing reduced RNAPII levels also had moderately reduced
RNAPII in the gene body (Figure 6D). Importantly, these
effects were restricted to CGI-associated genes, in agree-
ment with the function of KDM2A/B at CGIs. To exam-
ine in more detail the nature of the defects in RNAPII
function at CGI-associated gene promoters, we calculated
the RNAPII pausing index, which is often used a proxy
for RNAPII pause release (Supplementary Figure S6D).
This showed a modest but clear decrease in pausing index
when KDM2 proteins were removed (Figure 6E and Sup-
plementary Figure S6E), which we also validated by ChIP-
qPCR (Supplementary Figure S6F) and importantly this ef-
fect was not observed for non-CGI-associated genes. This
suggests that removal of KDM2 proteins may contribute
to an increased rate of RNAPII pause release from CGI-
associated gene promoters. A comparison of the changes
in RNAPII occupancy with the gene expression changes
following KDM2 removal revealed a moderate positive
correlation (Supplementary Figure S6G). Genes that de-
creased in expression lost RNAPII from both their pro-
moter and gene body, consistent with their reduced tran-
scriptional activity (Figure 6F and Supplementary Figure
S6H). In contrast, the genes that most strongly increased
in expression retained RNAPII at their promoter and had
elevated RNAPII occupancy throughout the gene body.
These effects on RNAPII could be explained by an increase
in the rate of transcription initiation at genes that show
large increases in expression which, when combined with
an increased rate of pause release, results in the accumula-
tion of RNAPII throughout the gene body and increases
in transcript levels. In contrast, there was a dramatic re-
duction of RNAPII occupancy at both the promoter and
body of genes which decreased in expression, consistent
with their reduced transcription. Importantly, the change
in the distribution of Ser5-phosphorylated RNAPII, which
is enriched at promoter regions, and Ser2-phosphorylated
RNAPII, which is enriched throughout gene bodies, resem-
bled that of total RNAPII (Supplementary Figure S6I).
There was no obvious shift in the position of either Ser2-
or Ser5-phosphorylated RNAPII enrichment throughout
CGI-associated genes (Figure 6G), and only minor changes
in the relative enrichment of Ser5- or Ser2-phosphorylated
RNAPII compared to total RNAPII at CGI gene promot-
ers and gene bodies, respectively (Figure 6H). Together our
findings suggest that KDM2 proteins play a role in regu-
lating RNAPII activity at gene promoters, potentially by
limiting initiation and pause release to constrain productive
transcription from these regions of the genome.
DISCUSSION
Chromatin modifying complexes are thought to play cen-
tral roles in regulating gene expression through their en-
zymatic activities. Yet, for most of these complexes, the
importance of their histone modifying activities in gene
regulation remains to be tested. KDM2 histone demethy-
lases have been proposed to contribute to an H3K36me2-
depleted and transcriptionally permissive chromatin state at
CGI-associated gene promoters (8,9). Alternatively, KDM2
demethylase activity has also been suggested to contribute
to gene repression in some specific instances (19,33–37).
However, the extent to which KDM2 proteins regulate
gene expression and how this is related to their H3K36me2
demethylase activity has remained untested. Here, using
combinatorial genetic perturbation and detailed genome-
wide approaches, we discover that the histone demethy-
lase activity of KDM2 proteins contributes modestly to
the H3K36me2 depletion at CGI-associated gene promot-
ers (Figure 1) and has minimal effects on gene expression
(Figure 2). In contrast, using calibrated gene expression
analysis we discover an unexpectedly widespread histone
demethylase-independent role for KDM2 proteins in con-
straining the expression of CGI-associated genes (Figure 3).
Importantly, repression byKDM2 proteins is not limited to
polycomb target genes, which are known to be regulated by
the KDM2B–PRC1 complex (Figure 4). Nevertheless, we
find that KDM2B plays the predominant role in repressing
expression, whilst KDM2A appears to contribute at a sub-
set of genes (Figure 5). Finally, the effects of KDM2 pro-
teins on gene expression are not mediated through changes
in chromatin accessibility, but instead KDM2 proteins ap-
pear to play a role in constraining RNAPII occupancy
and possibly pause release at CGI-associated gene promot-
ers to limit transcription (Figure 6). Together, this demon-
strates that KDM2 proteins regulate gene expression inde-
pendently of their histone demethylase activity and through
mechanisms that appear to regulate RNAPII function at
CGI-associated gene promoters. These discoveries reveal an
interesting new chromatin modification-independent role
for CGIs and the KDM2 proteins in constraining gene ex-
pression.
Our understanding of howhistonemodification states are
specified and regulated remains poorly understood. In the
context of histone H3K36, NSD1–3 and ASH1L, the main
H3K36me1/2 methyltransferases, can associate with gene
promoters and genic regions, andH3K36me2 blanketsmost
of the genome (74–79).However, our genome-wide profiling
of H3K36me2 reveals that the bodies of highly transcribed
genes and CGI-associated gene promoters are exceptions to
this, being uniquely depleted of H3K36me2. This suggests





























































































































































































































Figure 6. KDM2 proteins regulate RNAPII occupancy but not chromatin accessibility at CGI-associated gene promoters. (A) An MA-plot showing log2
fold change in the accessibility (cATAC-seq) of CGI-associated gene promoters in Kdm2a/b-CXXCfl/fl mESCs following tamoxifen treatment. No promot-
ers significantly changed in accessibility (p-adj < 0.05 and > 1.4-fold). (B) A heatmap of the fold change in RNAPII ChIP-seq signal following tamoxifen
treatment of Kdm2a/b-CXXCfl/fl mESCs, for CGI-associated (n = 14106) and non-CGI-associated (n = 6527) gene promoters. (C) A metaplot showing
RNAPII enrichment at CGI-associated genes before (UNT) and after tamoxifen treatment (OHT) of Kdm2a/b-CXXCfl/fl mESCs. (D) Genomic snap-
shots showing RNAPII occupancy before (UNT) and after tamoxifen treatment (OHT) of Kdm2a/b-CXXCfl/fl mESCs, for (above) a representative gene
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that mechanisms must function to shape H3K36me2 at dis-
tinct regions of the genome. The depletion of H3K36me2
in highly transcribed gene bodies is likely due to conver-
sion to H3K36me3 by the SETD2 protein, which inter-
acts with RNAPII and functions as an H3K36 trimethyl-
transferase in gene bodies during transcriptional elongation
(80–88). We and others had previously proposed that the
H3K36me2-depleted state at CGI-associated gene promot-
ers relies on KDM2 proteins to actively remove H3K36me2
from these regions. Now, using a cell system where we
can induce the removal of KDM2 demethylase activity,
we show that KDM2 enzymes contribute modestly to de-
pletion of H3K36me2 at CGI-associated gene promoters.
This suggests that the activity of NSD/ASH1L may be in-
hibited, or that other histone demethylases may compen-
sate for the loss of KDM2 enzymes, at these regions of
the genome. The latter of these two possibilities seems the
most likely, as KDM4A-C demethylases catalyse the re-
moval of H3K36me2/3 (89–92) and also associate broadly
with gene promoters (93,94). It is also possible that KDM2
demethylases initiate H3K36me2-depletion at CGIs and
othermechanisms, possibly includingKDM4demethylases,
are required for its maintenance. Therefore, determining
whether the H3K36me2-depleted state at CGI-associated
gene promoters results from active removal of this modi-
fication and contributes to gene regulation awaits further
investigation, including combinatorial removal of KDM2
and KDM4 demethylase activity.
When studied in the context of individual genes,
KDM2A and KDM2B have been proposed to function in
both gene activation and repression. However, which of
these activities is most prevalent and whether these par-
alogous proteins function together to achieve appropriate
gene regulation have remained unknown.Using combinato-
rial inducible genetic perturbation strategies and calibrated
RNA-seq we now reveal that KDM2 proteins function pri-
marily as repressors of gene expression and elicit their ef-
fects via a demethylase-independent mechanism. Gene re-
pression by KDM2 proteins is remarkably widespread but
largely restricted to CGI-associated genes, in agreement
with the occupancy of KDM2 proteins at these regions of
the genome through their ZF-CxxC DNA binding domain.
However, lowly expressed genes were more susceptible to
increases in gene expression when KDM2 proteins were re-
moved. Therefore, KDM2 proteins may function to generi-
cally constrain transcription fromCGI-associated gene pro-
moters, but only function to counteract low-level activation
signals. In agreement with this suggestion, CGI-associated
genes that are already highly expressed are largely unaf-
fected by KDM2 loss, despite the fact that KDM2 proteins
occupy their promoters. In the context of these observa-
tions, we propose that the repressive activity of KDM2 pro-
teins may effectively create a CGI-imposed barrier to gene
activation which protects against low-level or inappropriate
gene activation signals. This could be particularly impor-
tant in the context of cellular differentiation where excessive
gene expression noise or precocious gene activation may
have deleterious consequences for the highly orchestrated
cascade of gene expression events that lead to appropriate
acquisition of new cell fates. Indeed, whilst embryoid body
formation was largely unperturbed following loss ofKDM2
demethylase activity (Supplementary Figure S7A), removal
of KDM2 proteins from chromatin led to major gene ex-
pression defects and the failure to appropriately induce the
expression of a variety of developmental genes (Supplemen-
tary Figure S7B). This may be the consequence of inappro-
priate gene expression that manifests in the ESC state that
precludes induction of a normal differentiation programme.
Gene repression by the KDM2 proteins occurs indepen-
dently of their JmjC domain and histone demethylase ac-
tivity, raising the interesting question of how they repress
gene expression. By examining the binding of RNAPII and
its modified forms throughout the genome following loss of
KDM2 proteins, we discover that there is a widespread re-
duction in RNAPII occupancy at CGI-associated gene pro-
moters. This suggests that one activity of KDM2 proteins at
CGIsmay be to constrain productive transcription, perhaps
through a process that directly regulates RNAPII pause re-
lease. It is intriguing to note that, on average, RNAPII oc-
cupancymoderately decreased in gene bodies following loss
of KDM2 proteins, despite a widespread increase in gene
expression. This raises the possibility that there are further
alterations to RNAPII behaviour, such as elongation rate,
following KDM2 removal. Based on these observations, an
important area of future work will be to examine the mech-
anisms by which KDM2 proteins affect RNAPII activity
and to determine how direct this is.
We speculate that one mechanism by which KDM2 pro-
teins could potentially modulate RNAPII-dependent tran-
scription processes is through ubiquitylation. This is be-
cause, in addition to their JmjC domains, KDM2 proteins
also encode FBOX and LRR domains. FBOX domains
bind a protein called SKP1, and we and others have pre-
viously shown that KDM2A and KDM2B both interact
with SKP1 (15,40,95,96). SKP1 is a central component of
SCF-type E3 ubiquitin ligase complexes (97), whilst FBOX-
containing proteins are thought to confer substrate speci-
ficity for SCF complexes through additional domains such
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
that retains RNAPII at the promoter and increases in RNAPII occupancy throughout the gene body, and (below) a representative gene that decreases
in RNAPII at both promoter and gene body regions. BioCAP and KDM2A and KDM2B ChIP-seq signal are shown for reference (63). (E) Empirical
cumulative density function (ECDF) plots of RNAPII pausing index for CGI-associated (left) or non-CGI-associated (right) genes, before (UNT) and
after tamoxifen treatment (OHT) of Kdm2a/b-CXXCfl/fl mESCs. (F) Boxplots showing the fold change in RNAPII occupancy at CGI-associated gene
promoters (left) or gene bodies (right) following tamoxifen treatment of Kdm2a/b-CXXCfl/fl mESCs, for CGI-associated genes that significantly decreased
in expression, with no significant change in expression (‘non-sig’), or that significantly increased in expression. Genes that significantly increased in expres-
sion were separated into quartiles according to their log2 fold change in expression (Q1 < Q2 < Q3 < Q4). (G) Metaplots showing Ser5P-RNAPII (upper
panel) or Ser2P-RNAPII (lower panel) enrichment at CGI-associated genes before (UNT) and after tamoxifen treatment (OHT) of Kdm2a/b-CXXCfl/fl
mESCs. (H) A boxplot showing the fold change in Ser5P-RNAPII at gene promoters (left) or Ser2P-RNAPII at gene bodies (right) following tamoxifen
treatment of Kdm2a/b-CXXCfl/fl mESCs, normalized to RNAPII-NTD signal. The fold changes for CGI-associated and non-CGI-associated genes are
shown.
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as the LRRdomain (98). This suggests thatKDM2proteins
might identify target proteins for ubiquitylation. Indeed,
KDM2Bwas reported to ubiquitylate the transcription fac-
tor c-Fos, leading to its degradation by the proteasome (99).
KDM2A has also been proposed to possess E3 ligase ac-
tivity, as its overexpression stimulates 53BP1 ubiquitylation
(100). The specificity of these putative KDM2 E3 ubiqui-
tin ligase complexes remains to be investigated. However,
given that KDM2 proteins act broadly to repress gene ex-
pression and may regulate RNAPII activity, one might en-
visage that KDM2 proteins could regulate a component of
the core transcriptional machinery or another general mod-
ulator of gene transcription. Therefore, in future work it
will be interesting to explore whether KDM2 proteins have
a role in proteostasis at CGIs and to understand whether
this contributes to their function in the repression of gene
expression and the regulation of RNAPII activity.
In conclusion, we discover that KDM2 proteins are CGI-
specific transcriptional repressors that appear to function
to constrain low-level gene activation signals. Interestingly,
DNA situated in CGIs is known to be highly accessible,
differentiating it from much of the rest of the genome. It
has been proposed that this accessibility highlights the loca-
tion of gene regulatory elements within large and complex
vertebrate genomes, and allows transcriptional regulators
and the transcriptional machinery to more easily access the
underlying DNA and enable gene expression. However, an
unintended consequence of this CGI-associated accessibil-
ity may be that it renders these regions susceptible to low-
level and potentially inappropriate gene activation signals.
We speculate that, in response to this potentially deleterious
side effect of CGI accessibility, KDM2 proteins may have
evolved to bind CGIs and constrain transcription. Indeed,
we show that loss of KDM2 proteins does not affect acces-
sibly at CGIs but does broadly affect gene expression and
RNAPII occupancy. Therefore we propose that CGIs cre-
ate an appropriate balance of transcriptionally permissive
and restrictive activities to help control gene expression.
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